Terapia Ranbaxy, ZTE Interested In Taking Over Nokia's Romanian Facility

Romanian pharmaceutical company Terapia Ranbaxy and ZTE, one of the largest Chinese producers of telecom equipment, are interested in taking over Nokia's production halls at Jucu, once the plant closes, Alin Tise, president of the Cluj County Council, said on Tuesday.

44 views

Imaginea articolului Terapia Ranbaxy, ZTE Interested In Taking Over Nokia's Romanian Facility

Terapia Ranbaxy, ZTE Interested In Taking Over Nokia's Romanian Facility

Tise said Terapia Ranbaxy made "a serious offer" to take over the halls and extend its production capacity. The council has also been contacted by ZTE and two other investors, who have not decided whether they need additional land or Nokia's facility.

He pointed out that Nokia will decide who gets the halls, as per its contract with the county council.

In the Tetarom III Industrial Park at Jucu, Bosch is conducting tests for 20 hectares of land necessary for a future investment, said Tise. More than 60 hectares are still free in the park, aside from the 90 hectares held by the Nokia Village, which would have hosted Nokia's subcontractors.

The council is analyzing the contract with Nokia and its clauses on filling the Tetarom park with suppliers, to see whether the county is entitled to compensation.

Nokia announced recently it will shut down its Romanian production facility by the end of the year and move operations to Asia. The move will leave 2,200 people jobless.

The Ministry of Communications announced in August that ZTE will manufacture landline digital TV reception equipment in Romania. The Chinese company has plans to open a youth training center in Bucharest and is studying the market, with a view to setting up a factory in a disadvantaged area.

Ranbaxy Laboratories, India's largest medicine maker, bought Terapia Cluj-Napoca for $324 million in 2006.

If you liked this story, please follow MEDIAFAX.RO on FACEBOOK »

The content of mediafax.ro is for your information only. Republishing or using this content is forbidden without express consent of MEDIAFAX. For this consent, please ask for it by mail at vanzari@mediafax.ro.

 

The free download of the press materials (text, photo and / or video), bearers of intellectual property rights, is approved by www.mediafax.ro only within 250 signs. Spaces and URL / hyperlink are not taken into account when counting signs. The collection of information can only be done in accordance with the terms agreed and mentioned here